Zofran Lawsuit Update: Physicians Continue To Prescribe Drug “Off-Label”

November 30, 2015 – – ZofranLegal.com reports that as litigation surrounding anti-nausea drug Zofran continues to move forward, many physicians are still able to presrcibe the drug “off-label” to expectant mothers, a group for which the drug has never been safety tested on and has never gotten FDA-approval to treat. Despite this fact, the drug has been prescribed to an estimated 1 million pregnant women over the last year, and lawsuits linking this usage to birth defects in the unborn children continue to mount.

Zofran was approved by the U.S. Food and Drug Administration in 1991 to treat individuals dealing with severe nausea and vomiting episodes after undergoing radiation therapy, chemotherapy, or anesthesia. Allegations in the many lawsuits surrounding the drug state that despite this specific approval, manufacturer GlaxoSmithKline proceeded to market the drug to expectant mothers and OB/Gyns across the country as a treatment for nausea associated with morning sickness. Shortly after this marketing campaign began, however, GSK allegedly began to receive reports of children being born with birth defects if exposed to Zofran through their mothers while developing in utero.

Over the last two years, lawsuits have continued to be filed and add up, each commonly alleging that Zofran use by the mother has caused an unborn child to be born with severe defects. Most commonly, the defects noted are kidney defects, clubfoot, ventricular septal defect and atrial septal defect, transposition of the greater vessels, cleft lip and palate, and respiratory stress disorder. Several plaintiffs have claimed that their children passed away due to the severity of their birth defects, others have noted that their children required multiple corrective surgeries. Today, many of the plaintiffs involved in the current litigation wonder why the drug has continued to be prescribed to pregnant women.

As these plaintiffs await trial, it is anticipated that additional cases will appear. The attorneys at Monheit Law are working to ensure that everyone who was prescribed Zofran while pregnant and who subsequently delivered a baby with birth defects is able to explore their legal rights. It has been noted that these women, their families, and their children may be entitled to legal action and substantial compensation. Attorney Michael Monheit is currently offering free legal consultations to those involved.

To request additional information on Zofran birth defect lawsuits, or to ask questions, please call Michael Monheit, Esq. at (877) 620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005877